LeanLife Health

LeanLife closes first round of financing, raises $1.15 million

The offering consisted of 22.9 million units at a price of C$0.05 for total gross proceeds of $1,146,000 million

LeanLife's products are extracted from flax seeds, a plentiful and non-animal source of omega-3

LeanLife Health Inc (CSE:LLP) announced Friday it has closed its second round of funding, raising $1.14 million. 

The company said funds will be used for used for general working capital.

The offering consisted of 22.9 million units at a price of C$0.05 for total gross proceeds of $1,146,000 million. 

READ: LeanLife Health taps Chris Nichols as operations advisor

Each unit will consist of one share and one transferable share purchase warrant, which is exercisable into one further share at a price of C$0.075 per share for three years from closing.

LeanLife delivers high concentration levels of omega-3 as a nutritional additive. Its products are for use in commercial food processing. 

The group's products are extracted from flaxseeds, a plentiful and non-animal source of omega-3.

Such products will include ingredients for making and/or fortifying commercial foods such as bread, noodles, juices, yogurt and cheese.


Contact Katie Lewis at [email protected]

Quick facts: LeanLife Health

Price: $0.05

Market: CSE
Market Cap: $4.81 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LeanLife Health named herein, including the promotion by the Company of LeanLife Health in any Content on the Site, the Company receives from...


2 min read